Atlas Trials

MONO: Symbicort® Single Inhaler Therapy and Conventional Best Standard Treatment for the Treatment of Persistent Asthma in Adolescents and Adults

Clinical trial NCT00242411 · COMPLETED

Trial details

NCT number
NCT00242411
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Asthma
Start date
2004-09-01
Primary completion
2006-10-01
Enrollment
1900

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.